{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:15:19Z","timestamp":1783721719353,"version":"3.55.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>\n                      Procedures have traditionally been delayed 6 to 12 months after isotretinoin because of concerns about abnormal scarring; evidence for fractional ablative CO\n                      <jats:sub>2<\/jats:sub>\n                      laser is limited in higher Fitzpatrick skin types.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      To assess the safety and effectiveness of ablative fractional CO\n                      <jats:sub>2<\/jats:sub>\n                      laser (AFCL) for atrophic acne scars during and after oral isotretinoin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This was a single-center retrospective cohort of 106 patients (188 AFCL sessions) grouped as concurrent isotretinoin, \u226490 days since discontinuation, 91 to 180 days, or &gt;180 days (control). Outcomes included abnormal scarring, delayed re-epithelialization (&gt;14 days), postinflammatory hyperpigmentation (PIH) at 1 and 3 months, and scar-score change. Overall group comparisons and adjusted patient-level and session-level models were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Abnormal scarring occurred in 3\/106 patients (2.8%) with no significant between-group difference (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .762). Delayed re-epithelialization &gt;14 days occurred in 11\/106 patients (10.4%) and was numerically highest in the concurrent isotretinoin group (6\/31 [19.4%]); however, the overall four-group comparison was not significant (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .243), and concurrent isotretinoin was not statistically significant in an adjusted session-level generalized estimating equation model (OR: 4.79, 95% confidence interval: 0.79\u201329.13;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .089). PIH at 3 months was higher in the \u226490-day group versus controls (adjusted OR: 6.03, 95% confidence interval: 1.55\u201323.52;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .010). Concurrent isotretinoin was not associated with increased PIH or abnormal scarring. Higher density predicted delayed re-epithelialization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>AFCL during low-dose isotretinoin or within 6 months after isotretinoin discontinuation was not associated with increased abnormal scarring. Because delayed re-epithelialization was numerically more frequent during concurrent isotretinoin and density was associated with slower healing, conservative density selection and careful counseling remain appropriate. PIH risk was elevated when treatment occurred within 90 days after discontinuation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000005260","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:02:33Z","timestamp":1783720953000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Ablative Fractional CO2 Laser Resurfacing for Atrophic Acne Scars During and After Oral Isotretinoin: A Single-Center Retrospective Cohort Study in Fitzpatrick III\u2013VI Patients"],"prefix":"10.1097","author":[{"given":"Zhe","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"R1-20260710","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0190-9622(86)70167-9","article-title":"Atypical keloids after dermabrasion of patients taking isotretinoin","volume":"15","author":"Rubenstein","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"R2-20260710","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2133.1988.tb02574.x","article-title":"Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment","volume":"118","author":"Zachariae","year":"1988","journal-title":"Br J Dermatol"},{"key":"R3-20260710","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0190-9622(94)70096-6","article-title":"Atypical facial scarring after isotretinoin therapy in a patient with previous dermabrasion","volume":"30","author":"Katz","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"R4-20260710","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamadermatol.2017.2077","article-title":"Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations","volume":"153","author":"Spring","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R5-20260710","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/DSS.0000000000001166","article-title":"ASDS guidelines task force: consensus recommendations regarding the safety of lasers, dermabrasion, chemical peels, energy devices, and incisional\/excisional surgery during and after isotretinoin use","volume":"43","author":"Waldman","year":"2017","journal-title":"Dermatol Surg"},{"key":"R6-20260710","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.1111\/dth.14022","article-title":"Concomitant use of isotretinoin and lasers with implications for future guidelines: an updated systematic review","volume":"33","author":"Mirza","year":"2020","journal-title":"Dermatol Ther"},{"key":"R7-20260710","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/DSS.0000000000000185","article-title":"The safe delivery of fractional ablative carbon dioxide laser treatment for acne scars in Asian patients receiving oral isotretinoin","volume":"40","author":"Kim","year":"2014","journal-title":"Dermatol Surg"},{"key":"R8-20260710","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/lsm.23713","article-title":"Fractional ablative CO2 laser and oral isotretinoin\u2014A prospective randomized controlled split-face trial comparing concurrent versus delayed laser treatment for acne scars","volume":"56","author":"Taleb","year":"2024","journal-title":"Lasers Surg Med"},{"key":"R9-20260710","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/lsm.70056","article-title":"Ablative fractional CO2 laser treatment with and without oral isotretinoin: a study on side effects and acne scars improvement in Southeast Asians","volume":"57","author":"Rujirawan","year":"2025","journal-title":"Lasers Surg Med"},{"key":"R10-20260710","first-page":"615","article-title":"Fractional ablative carbon dioxide laser resurfacing for skin rejuvenation and acne scars in Asians","volume":"42","author":"Chan","year":"2010","journal-title":"Lasers Surg Med"},{"key":"R11-20260710","first-page":"1458","article-title":"Postacne scarring: a qualitative global scarring grading system","volume":"32","author":"Goodman","year":"2006","journal-title":"Dermatol Surg"},{"key":"R12-20260710","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000096912","article-title":"ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology","volume":"214","author":"Dr\u00e9no","year":"2007","journal-title":"Dermatology"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000005260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:02:34Z","timestamp":1783720954000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000005260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":12,"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000005260","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}